Results 221 to 230 of about 439,222 (363)

Profound Thrombocytopenia and Dyspnea 11 Days After Cardiac Surgery

open access: yes
American Journal of Hematology, EarlyView.
Sebastian Vuong   +3 more
wiley   +1 more source

Thrombocytopenia and Anemia After Cardiac Surgery

open access: yes
American Journal of Hematology, EarlyView.
Myriam Beshai   +2 more
wiley   +1 more source

Long-term follow up after third-party viral-specific cytotoxic lymphocytes for immunosuppression- and Epstein-Barr virus-associated lymphoproliferative disease

open access: yesHaematologica, 2019
Sajida Kazi   +11 more
doaj   +1 more source

Trends and Outcomes Following Percutaneous Coronary Intervention in Patients With Myeloproliferative Neoplasms: Insights From National Database

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Myeloproliferative neoplasms (MPN) are associated with an increased cardiovascular risk including acute coronary syndrome. However, there is a lack of comprehensive data regarding the rate of percutaneous coronary intervention (PCI), as well as the in‐hospital characteristics and outcomes for MPN patients.
Song Peng Ang   +8 more
wiley   +1 more source

Dual Antiplatelet Therapy Prior to Percutaneous Coronary Intervention for Acute Coronary Syndrome: Prevalence and Outcomes in Contemporary Practice

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Dual antiplatelet therapy (DAPT) is standard following percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS). Preloading is the practice of administering both aspirin and a P2Y12 inhibitor before PCI. DAPT preloading is common practice, however clinical trial evidence demonstrating benefit is lacking.
Shi Hui Goh   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy